Thomas Hohman,Janet Cheetham,Scott Whitcup,Erik Lippa
申请号：
US15230244
公开号：
US20170157207A1
申请日:
2016.08.05
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Disclosed herein are methods for the treatment of a patient having an exudative age-related macular degeneration and other conditions of the retina by administering a binding protein comprising an ankyrin repeat domain, wherein the binding protein is first administered in 2 to 5 doses, with an interval of 25 to 35 days between each dose, and then is administered in additional doses with a longer interval between doses.
